Intervacc AB (publ) (STO:IVACC)
Sweden · Delayed Price · Currency is SEK 0.8680
-0.0150 (-1.70%)
Oct 13, 2026, 11:47 AM CET
Intervacc AB Market Cap
Intervacc AB has a market cap or net worth of 295.83 million as of October 12, 2026. It is the 34,159th most valuable company in the world and the 461st biggest in Sweden. Its market cap has decreased by 18.88% in one year.
Market Cap
295.83M
Enterprise Value
169.05M
Revenue
18.11M
Global Rank
Country Rank
#461 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since April 7, 2017, Intervacc AB's market cap has increased from 85.80M to 295.83M, an increase of 244.81%. That is a compound annual growth rate of 13.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 295.83M | -6.06% |
| Dec 30, 2025 | 314.91M | 255.38% |
| Dec 30, 2024 | 88.61M | -81.52% |
| Dec 29, 2023 | 479.41M | -63.48% |
| Dec 30, 2022 | 1.31B | -50.81% |
| Dec 30, 2021 | 2.67B | 0.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 7, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xspray Pharma AB | 521.58M |
| FluoGuide | 513.37M |
| Sprint Bioscience AB | 395.68M |
| Cantargia AB | 364.27M |
| Corline Biomedical AB | 354.10M |
| Mendus AB | 351.47M |
| IRLAB Therapeutics AB | 273.33M |
| Xbrane Biopharma AB | 258.60M |